Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-29 23:55 | 2025-07-25 | ALZN | Alzamend Neuro Inc. | AULT MILTON C III | Director, 10% owner | SELL | $2.86 | 44,843 | $128,170 | 37,709 |
| 2025-07-29 01:08 | 2025-07-25 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Director, Officer | SELL | $54.78 | 10,415 | $570,534 | 520,603 |
| 2025-07-25 23:00 | 2025-07-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | SELL | $805.07 | 280,000 | $225,419,264 | 95,736,978 |
| 2025-07-26 00:22 | 2025-07-23 | IRON | Disc Medicine, Inc. | Bitterman Kevin | Director | SELL | $61.03 | 42,870 | $2,616,390 | 633,969 |
| 2025-07-26 01:54 | 2025-07-23 | DMAC | DiaMedica Therapeutics Inc. | STAHLBERG JAN | 10% owner | BUY | $3.50 | 1,542,857 | $5,400,000 | 6,764,465 |
| 2025-07-26 00:49 | 2025-07-23 | DMAC | DiaMedica Therapeutics Inc. | Von Koch Thomas | 10% owner | BUY | $3.50 | 2,857,142 | $9,999,997 | 8,383,577 |
| 2025-07-26 01:24 | 2025-07-25 | CNTA | Centessa Pharmaceuticals plc | Weinhoff Gregory M | Officer | OPT+S | $15.56 | 10,000 | $155,598 | 122,279 |
| 2025-07-26 03:00 | 2025-07-23 | ALZN | Alzamend Neuro Inc. | AULT MILTON C III | Director, 10% owner | SELL | $2.95 | 69,137 | $203,823 | 82,552 |
| 2025-07-25 23:35 | 2025-07-23 | DMAC | DiaMedica Therapeutics Inc. | JACINTO RICHARD II | 10% owner | BUY | $3.50 | 400,000 | $1,400,000 | 4,958,823 |
| 2025-07-26 01:56 | 2025-07-24 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | Officer | OPT+S | $304.11 | 11,000 | $3,345,225 | 36,781 |
| 2025-07-26 01:05 | 2025-07-10 | ELTP | ELITE PHARMACEUTICALS INC /NV/ | Kirkov Kirko | Officer | BUY | $0.59 | 16,366 | $9,640 | 16,366 |
| 2025-07-25 00:00 | 2025-07-22 | CYRX | Cryoport, Inc. | Mandalam Ramkumar | Director | OPT+S | $7.24 | 40,728 | $294,899 | 92,328 |
| 2025-07-23 23:30 | 2025-07-21 | LQDA | Liquidia Corp | Saggar Rajeev | Officer | SELL | $14.54 | 2,526 | $36,728 | 268,887 |
| 2025-07-24 01:09 | 2025-07-22 | HOOK | HOOKIPA Pharma Inc. | Peters Malte | Director, Officer | SELL | $0.92 | 29,176 | $26,842 | 79,519 |
| 2025-07-24 01:07 | 2025-07-22 | HOOK | HOOKIPA Pharma Inc. | Coelho Mary Theresa | Director, Officer | SELL | $0.92 | 13,609 | $12,520 | 56,266 |
| 2025-07-24 01:52 | 2025-07-21 | ELVN | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Officer | SELL | $22.29 | 12,500 | $278,646 | 952,688 |
| 2025-07-24 04:00 | 2025-07-21 | ROIV | Roivant Sciences Ltd. | Venker Eric | Officer | OPT+S | $11.52 | 100,000 | $1,152,000 | 1,462,223 |
| 2025-07-23 18:55 | 2025-07-22 | CALC | CalciMedica, Inc. | Roberts Eric W | Director, Officer, 10% owner | BUY | $3.78 | 1,500 | $5,663 | 49,323 |
| 2025-07-24 00:18 | 2025-07-22 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | Officer | SELL | $4.00 | 238 | $952 | 9,475 |
| 2025-07-23 23:16 | 2025-07-21 | SGMT | Sagimet Biosciences Inc. | Happel David | Director, Officer | SELL | $9.13 | 65,478 | $598,115 | 689,722 |
| 2025-07-23 23:15 | 2025-07-21 | SGMT | Sagimet Biosciences Inc. | Martins Eduardo Bruno | Officer | SELL | $9.13 | 8,277 | $75,607 | 106,936 |
| 2025-07-23 23:14 | 2025-07-21 | SGMT | Sagimet Biosciences Inc. | Rozek Elizabeth | Officer | SELL | $9.13 | 10,780 | $98,471 | 183,726 |
| 2025-07-24 01:57 | 2025-07-21 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Director, Officer | SELL | $54.92 | 52,444 | $2,880,046 | 531,018 |
| 2025-07-23 23:35 | 2025-07-21 | INSM | INSMED Inc | Bonstein Sara | Officer | OPT+S | $102.67 | 58,400 | $5,996,092 | 73,505 |
| 2025-07-23 18:01 | 2025-07-22 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | Officer | OPT+S | $37.47 | 2,000 | $74,940 | 140,610 |
| 2025-07-22 23:15 | 2025-07-22 | ABEO | Abeona Therapeutics Inc. | Vazzano Joseph Walter | Officer | SELL | $6.64 | 1,502 | $9,975 | 477,666 |
| 2025-07-22 23:54 | 2025-07-18 | ONC | BeOne Medicines Ltd. | Wang Lai | Officer | SELL | $300.00 | 700 | $210,000 | 0 |
| 2025-07-22 23:44 | 2025-07-18 | IRON | Disc Medicine, Inc. | Bitterman Kevin | Director | SELL | $61.13 | 664 | $40,590 | 676,839 |
| 2025-07-22 22:24 | 2025-07-22 | ETST | Earth Science Tech, Inc. | Saumat Giorgio R. | Director, Officer, 10% owner | BUY | $0.21 | 50,000 | $10,250 | 122,930,127 |
| 2025-07-22 19:15 | 2025-07-21 | CALC | CalciMedica, Inc. | Roberts Eric W | Director, Officer, 10% owner | BUY | $3.37 | 1,500 | $5,055 | 47,823 |
| 2025-07-23 02:51 | 2025-07-18 | PBYI | PUMA BIOTECHNOLOGY, INC. | Cesano Alessandra | Director | SELL | $3.37 | 27,000 | $90,909 | 41,850 |
| 2025-07-22 17:25 | 2025-07-21 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer | OPT+S | $5.34 | 6,500 | $34,710 | 0 |
| 2025-07-23 00:08 | 2025-07-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | OPT+S | $350.01 | 1,000 | $350,005 | 461,044 |
| 2025-07-23 00:06 | 2025-07-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | OPT+S | $350.03 | 1,400 | $490,044 | 187,164 |
| 2025-07-22 14:36 | 2025-07-21 | GALT | GALECTIN THERAPEUTICS INC | ELDRED KARY | Director | BUY | $2.93 | 1,000 | $2,925 | 64,682 |
| 2025-07-22 02:39 | 2025-07-21 | CNTA | Centessa Pharmaceuticals plc | SAHA SAURABH | Director, Officer | OPT+S | $15.92 | 55,000 | $875,600 | 221,017 |
| 2025-07-21 15:30 | 2025-07-18 | ANIX | Anixa Biosciences Inc. | Baskies Arnold M | Director | BUY | $3.39 | 5,000 | $16,950 | 125,000 |
| 2025-07-22 02:21 | 2025-07-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Director, Officer | SELL | $22.52 | 12,500 | $281,518 | 940,392 |
| 2025-07-21 23:42 | 2025-07-21 | ETST | Earth Science Tech, Inc. | Saumat Giorgio R. | Director, Officer, 10% owner | BUY | $0.20 | 100,000 | $20,000 | 122,880,127 |
| 2025-07-21 21:02 | 2025-07-21 | CALC | CalciMedica, Inc. | Leheny A. Rachel | Director, Officer, 10% owner | BUY | $3.40 | 1,000 | $3,400 | 3,500 |
| 2025-07-22 02:14 | 2025-07-17 | CORT | CORCEPT THERAPEUTICS INC | Maduck Sean | Officer | OPT+S | $73.47 | 4,788 | $351,791 | 17,705 |
| 2025-07-22 02:11 | 2025-07-17 | CORT | CORCEPT THERAPEUTICS INC | BELANOFF JOSEPH K | Director, Officer | SELL | $73.69 | 615 | $45,318 | 2,901,370 |
| 2025-07-22 02:10 | 2025-07-17 | CORT | CORCEPT THERAPEUTICS INC | Lyon Joseph Douglas | Officer | OPT+S | $73.47 | 4,077 | $299,544 | 10,066 |
| 2025-07-22 02:10 | 2025-07-17 | CORT | CORCEPT THERAPEUTICS INC | Guyer William | Officer | OPT+S | $73.48 | 4,879 | $358,495 | 5,487 |
| 2025-07-21 23:15 | 2025-07-17 | AIMD | Ainos Inc. | Taiwan Carbon Nano Technology Corp | 10% owner | SELL | $2.81 | 14,001 | $39,273 | 1,080,103 |
| 2025-07-18 23:05 | 2025-07-16 | PHAT | Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Officer | SELL | $8.36 | 1,692 | $14,152 | 48,392 |
| 2025-07-19 01:00 | 2025-07-16 | AKRO | Akero Therapeutics, Inc. | Yale Catriona | Officer | OPT+S | $52.95 | 10,000 | $529,467 | 91,488 |
| 2025-07-18 23:51 | 2025-07-17 | IRON | Disc Medicine, Inc. | Franchi Jean M. | Officer | SELL | $59.00 | 2,031 | $119,829 | 63,499 |
| 2025-07-18 23:05 | 2025-07-17 | MRUS | Merus N.V. | Silverman Peter B. | Officer | OPT+S | $60.00 | 25,000 | $1,500,000 | 0 |
| 2025-07-18 21:36 | 2025-07-18 | CALC | CalciMedica, Inc. | Roberts Eric W | Director, Officer, 10% owner | BUY | $2.88 | 2,000 | $5,760 | 46,323 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.